⌕
Climb Bio · CLYM · Nasdaq
Tenet 62 · Solid
Compare
$9.78−1.61%At closeTenet 62 · Solid
$9.78−0.16 (−1.61%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Climb Bio (CLYM) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business enginePre-revenue: no positive revenue in any year through FY25, so the growth and margin read is withheld. Worth your attention in FY25: Share count (+453.1%) and Returns vs FCF (n/m). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)—
0.0
FY21→FY25CAGR —
Net income ($M)▲19.0%
−59.9
FY21→FY25CAGR —
Free cash flow ($M)▼250.5%
−54.5
no value for 2 of 5 yearsCAGR —
Diluted EPS▲42.5%
−0.88
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+453.1%

12.3mn → 67.8mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Returns vs FCF
n/m

$0.1M returned vs $−54.5M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)0.0Revenue0.0COGS0.0Gross profit−46.7R&D−21.2SG&A−67.9Op income8.0Tax & other−59.9Net income

Margin trend · direction beats level
108530%sector median net margin ~3%FY21FY25

This filer reports no gross profit or operating income line, so those margins are not drawn.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
—0.00.00.00.00.0——
Cost of revenue
—0.00.00.00.00.0——
Gross profit
—0.00.00.00.00.0——
Research & development
43,869.046,713.065,995.015,411.026,214.023,322.0▼29.2%+19.0%
Selling, general & admin
22,890.021,170.016,025.024,864.018,921.012,350.0▲32.1%+14.4%
Total operating expenses
66,759.067,883.082,020.040,275.045,135.035,672.0▼17.2%+17.5%
Operating incomefeeds ROC rank
−66,759.0−67,883.0−82,020.0−40,275.0−45,135.0−35,672.0▲17.2%—
Other income, net
7,450.08,032.08,123.05,156.0−109.0−11,808.0——
Pretax income
−59,309.0−59,851.0−73,897.0−35,119.0−45,244.0−47,480.0▲19.0%—
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−59,309.0−59,851.0−73,897.0−35,119.0−45,244.0−47,480.0▲19.0%—
Per share
Diluted EPSbuyback-sensitive
−0.81−0.88−1.53−1.30−1.72−4.24▲42.5%—
Diluted shares (mn)
80.0367.8148.1626.9926.3112.26▲40.8%+53.4%
Margins
† TTM = trailing four quarters through 2026-09-30.
FY20 – FY20 · 1 more year
Unlock the full history →
1 more year of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-03-05 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.